ContextVision reported strong sales in Q1, reaching 21.1 MSEK, 9% higher than the first quarter last year. The company reports positive feedback from user tests within digital pathology and continues to proceed with product development for this fast-growing market.
ContextVision Earns Acclaim from Frost & Sullivan for Its AI-powered INIFY™ Prostate Cancer Screening Platform
Based on its recent analysis of the European prostate cancer screening market, Frost & Sullivan recognises the Stockholm-based ContextVision AB with the 2019 European Technology Leadership Award for its INIFY™ Prostate platform.
Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail .